Supreme Court Asked to Pause Abortion Pill Access Ruling

Danco Laboratories, the maker of mifepristone, seeks Supreme Court intervention after a fifth circuit court ruling ended mail-order access nationwide, forcing in-person clinic visits. The decision, which overrides FDA rules, was a result of Louisianas attorney generals lawsuit against the FDA. Abortion opponents celebrate it as a win for life, while supporters argue its out of step with science and public will. The ruling also threatens shield laws in blue states protecting mail providers. With midterms approaching, abortion access remains a contentious issue, testing voter sentiment post-Roe and pushing leaders to take sides. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/0f6cec7555e5392c